Forest's $65M Settlement Over Antidepressants OK'd

Law360 (December 29, 2008, 12:00 AM EST) -- A judge has given preliminary approval to a $65 million settlement that allows Forest Laboratories to end a securities class action that claimed it provided misleading information about the safety of its blockbuster antidepressants Celexa and Lexapro.

In an order Dec. 23, Judge Richard M. Berman of the U.S. District Court for the Southern District of New York tentatively signed off on the deal. He scheduled a final hearing on the matter for April 23 and set a schedule for notification of class members.

Forest had...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

In re Forest Laboratories, Inc. Securities Litigation


Case Number

1:05-cv-02827

Court

New York Southern

Nature of Suit

Securities/Commodities

Judge

Richard M. Berman

Date Filed

March 11, 2005

Law Firms

Companies

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.